{
  "trial_id": "NCT03975855",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "cT1-4c",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Female / male patient aged \u2265 18 years",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Written informed consent (ICF)",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Suspicious lymph nodes after neoadjuvant therapy",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "No confirmed breast cancer and no abnormality in the breast",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "45-year-old postmenopausal woman with cytologically confirmed breast cancer, HER2-positive and ER/PR negative.",
  "_meta": {
    "topic_id": "61",
    "trial_id": "NCT03975855",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}